"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
DOSAGE AND ADMINISTRATION
Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
PRED FORTE® (prednisolone acetate ophthalmic suspension) (prednisolone acetate ophthalmic suspension, USP ) 1% is supplied sterile in opaque white LDPE plastic bottles with droppers with white high impact polystyrene (HIPS) caps as follows:
1 mL in 5 mL bottle - NDC 11980-180-01
5 mL in 10 mL bottle - NDC 11980-180-05
10 mL in 15 mL bottle - NDC 11980-180-10
15 mL in 15 mL bottle - NDC 11980-180-15
Note: Store at temperatures up to 25°C (77°F). Protect from freezing. Store in an upright position.
Revised March 2004. Allergan, Inc. Irvine, CA 92612, U.S.A.
Last reviewed on RxList: 5/6/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Pred Forte Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.